NCT00004373View on ClinicalTrials.gov

Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 1997

Study Completion Date

March 31, 2001

Conditions
Anxiety DisorderPanic Disorder
Interventions
DRUG

alprazolam

Trial Locations (1)

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH